Tag:
targeted therapies
Latest Headlines
Latest Headlines
GSK lands one-two punch in melanoma trial
Data from the small mid-stage trial provide early evidence that GSK's two-drug combo could have an edge over Roche's approved melanoma drug Zelboraf.
Big trouble seen for targeted cancer drugs
Researchers have discovered that the genetic complexities of cancer could thwart current methods of matching a patient's tumor with targeted drugs.
Genomics revolution ignites new M&A talk, showstoppers
Roche's $5.7 billion hostile bid to scoop up DNA sequencing machine maker Illumina ( $ILMN ) has triggered talk of further merger targets in the promising genomics arena.
